Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lignocaine for donor site pain after split skin grafting in major burns
ACTRN12619000100190Phase 4Recruiting
- Sponsor
- Alfred Health
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Lignocaine plus standard therapy with Saline placebo plus standard therapy (2 arms). Primary endpoint: Difference in donor site numerical rating pain score between groups. Started Mar 2019; status: recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12619000100190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000100190.